Deletion of the GI-2 integrase and the wbkA flanking transposase improves the stability of Brucella melitensis Rev 1 vaccine

dc.contributor.authorMancilla, Marcos
dc.contributor.authorGrilló Dolset, María Jesús
dc.contributor.authorMiguel López, María Jesús de
dc.contributor.authorLópez Goñi, Ignacio
dc.contributor.authorSan Román Aberasturi, Beatriz
dc.contributor.authorZabalza Baranguá, Ana
dc.contributor.authorMoriyón Uría, Ignacio
dc.contributor.departmentIdAB. Instituto de Agrobiotecnología / Agrobioteknologiako Institutuaes_ES
dc.date.accessioned2014-06-20T06:37:11Z
dc.date.available2014-06-20T06:37:11Z
dc.date.issued2013
dc.description.abstractBrucella melitensis Rev 1 is the best vaccine available for the prophylaxis of small ruminant brucellosis and, indirectly, for reducing human brucellosis. However, Rev 1 shows anomalously high rates of spontaneous dissociation from smooth (S) to rough (R) bacteria, the latter being inefficacious as vaccines. This S-R instability results from the loss of the O-polysaccharide. To overcome this problem, we investigated whether some recently described mechanisms promoting mutations in O-polysaccharide genes were involved in Rev 1 S-R dissociation. We found that a proportion of Rev 1 R mutants result from genome rearrangements affecting the wbo O-polysaccharide loci of genomic island GI-2 and the wbkA O-polysaccharide glycosyltransferase gene of the wbk region. Accordingly, we mutated the GI-2 int gene and the wbk IS transposase involved in those arrangements, and found that these Rev 1 mutants maintained the S phenotype and showed lower dissociation levels. Combining these two mutations resulted in a strain (Rev 2) displaying a 95% decrease in dissociation with respect to parental Rev 1 under conditions promoting dissociation. Rev 2 did not differ from Rev 1 in the characteristics used in Rev 1 typing (growth rate, colonial size, reactivity with O-polysaccharide antibodies, phage, dye and antibiotic susceptibility). Moreover, Rev 2 and Rev 1 showed similar attenuation and afforded similar protection in the mouse model of brucellosis vaccines. We conclude that mutations targeting genes and DNA sequences involved in spontaneous O-polysaccharide loss enhance the stability of a critical vaccine phenotype and complement the empirical stabilization precautions taken during S Brucella vaccine production.en
dc.description.sponsorshipThis work was funded by MINECO (reference project AGL2011-30453-C04) of Spain, the FIMA foundation and the European Union’s FP7/2007-2013 (grant agreement n° 221948, ICONZ - Integrated control of Neglected Zoonoses) and CSIC JAE-Doc program (FSE).en
dc.format.mimetypeapplication/pdfen
dc.identifier.doi10.1186/1297-9716-44-105
dc.identifier.issn1297-9716 (electronic)
dc.identifier.issn0928-4249 (print)
dc.identifier.other1278
dc.identifier.urihttps://academica-e.unavarra.es/handle/2454/10926
dc.language.isoengen
dc.publisherBioMed Centralen
dc.relation.ispartofVeterinary Research, 2013, 44:105en
dc.relation.projectIDinfo:eu-repo/grantAgreement/European Commission/FP7/221948/
dc.relation.projectIDinfo:eu-repo/grantAgreement/MICINN//AGL2011-30453-C04-03/ES/
dc.relation.publisherversionhttps://dx.doi.org/10.1186/1297-9716-44-105
dc.rights© 2013 Mancilla et al.; licensee BioMed Central Ltd. This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.en
dc.rights.accessRightsinfo:eu-repo/semantics/openAccess
dc.rights.urihttps://creativecommons.org/licenses/by/2.0/
dc.subjectGeneen
dc.subjectPCR assayen
dc.subjectGram-negative bacteriaen
dc.subjectGenomic islanden
dc.subjectIdentificationen
dc.subjectO-polysaccharide synthesisen
dc.subjectDNA polymorphismen
dc.subjectAbortusen
dc.subjectSmooth lipopolysaccharideen
dc.subjectVirulenceen
dc.titleDeletion of the GI-2 integrase and the wbkA flanking transposase improves the stability of Brucella melitensis Rev 1 vaccineen
dc.typeinfo:eu-repo/semantics/article
dc.type.versioninfo:eu-repo/semantics/publishedVersion
dspace.entity.typePublication
relation.isAuthorOfPublicationb22c2d43-7818-468c-b24a-8acde1b7ae80
relation.isAuthorOfPublication618f91fb-38b4-4e6c-b43b-12075328c848
relation.isAuthorOfPublication.latestForDiscoveryb22c2d43-7818-468c-b24a-8acde1b7ae80

Files

Original bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
1278.pdf
Size:
1.35 MB
Format:
Adobe Portable Document Format
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed to upon submission
Description: